Jundishapur Journal of Microbiology

Published by: Kowsar

Isolation and Characterization of a Myoviridae MJ1 Bacteriophage Against Multi-Drug Resistant Escherichia coli 3

Muhsin Jamal 1 , 2 , * , Tahir Hussain 1 , Chythanya Rajanna Das 2 and Saadia Andleeb 1
Authors Information
1 Atta-ur-Rahman School of Applied Biosciences (ASAB), National University of Sciences and Technology (NUST), Islamabad, Pakistan
2 Emerging Pathogens Institute (EPI), University of Florida (UF), Florida, USA
Article information
  • Jundishapur Journal of Microbiology: November 01, 2015, 8 (11); e25917
  • Published Online: November 21, 2015
  • Article Type: Research Article
  • Received: December 8, 2014
  • Revised: June 17, 2015
  • Accepted: July 10, 2015
  • DOI: 10.5812/jjm.25917

To Cite: Jamal M, Hussain T, Rajanna Das C, Andleeb S. Isolation and Characterization of a Myoviridae MJ1 Bacteriophage Against Multi-Drug Resistant Escherichia coli 3, Jundishapur J Microbiol. 2015 ; 8(11):e25917. doi: 10.5812/jjm.25917.

Copyright © 2015, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
  • 1. Pfaller MA, Jones RN. MYSTIC (Meropenem Yearly Susceptibility Test Information Collection) results from the Americas: resistance implications in the treatment of serious infections. MYSTIC Study Group (Americas). J Antimicrob Chemother. 2000; 46 Suppl T2: 25-37[PubMed]
  • 2. Hussain T, Jamal M, Nighat F, Andleeb S. Broad Spectrum Antibiotics and Resistance in Non-target Bacteria: An Example from Tetracycline. J Pure Appl Microbiol. 2014; 8(4): 2667-71
  • 3. Alizade H, Ghanbarpour R, Nekoubin M. Phylogenetic of Shiga Toxin-Producing Escherichia coli and Atypical Enteropathogenic Escherichia coli Strains Isolated From Human and Cattle in Kerman, Iran. Int J Enteric Pathogens. 2014; 2(1)[DOI]
  • 4. Surette MG, Miller MB, Bassler BL. Quorum sensing in Escherichia coli, Salmonella typhimurium, and Vibrio harveyi: a new family of genes responsible for autoinducer production. Proc Natl Acad Sci U S A. 1999; 96(4): 1639-44[PubMed]
  • 5. Naves P, del Prado G, Huelves L, Rodriguez-Cerrato V, Ruiz V, Ponte MC, et al. Effects of human serum albumin, ibuprofen and N-acetyl-L-cysteine against biofilm formation by pathogenic Escherichia coli strains. J Hosp Infect. 2010; 76(2): 165-70[DOI][PubMed]
  • 6. Choisy C. Biofilms and public health, [in French]. Bull. Acad. Natl. Med. 2010; 195(4-5): 1118-20[PubMed]
  • 7. Rao V, Ghei R, Chambers Y. Biofilms research-implications to biosafety and public health. Appl Biosafety. 2005; 10(2): 83
  • 8. Jamala M, Hussaina T, Dasb C, Andleeba S. Inhibition of clinical multi-drug resistant Klebsiella pneumoniae biofilm by Siphoviridae bacteriophage Z. Sci Lett. 2015; 3(2): 122-6
  • 9. Hughes KA, Sutherland IW, Clark J, Jones MV. Bacteriophage and associated polysaccharide depolymerases--novel tools for study of bacterial biofilms. J Appl Microbiol. 1998; 85(3): 583-90[PubMed]
  • 10. Sulakvelidze A, Alavidze Z, Morris JJ. Bacteriophage therapy. Antimicrob Agents Chemother. 2001; 45(3): 649-59[DOI][PubMed]
  • 11. Ashelford KE, Norris SJ, Fry JC, Bailey MJ, Day MJ. Seasonal population dynamics and interactions of competing bacteriophages and their host in the rhizosphere. Appl Environ Microbiol. 2000; 66(10): 4193-9[PubMed]
  • 12. Casjens SR. Diversity among the tailed-bacteriophages that infect the Enterobacteriaceae. Res Microbiol. 2008; 159(5): 340-8[DOI][PubMed]
  • 13. Watnick P, Kolter R. Biofilm, city of microbes. J Bacteriol. 2000; 182(10): 2675-9[PubMed]
  • 14. Jamal M, Chaudhry WN, Hussain T, Das CR, Andleeb S. Characterization of new Myoviridae bacteriophage WZ1 against multi-drug resistant (MDR) Shigella dysenteriae. J Basic Microbiol. 2015; 55(4): 420-31[DOI][PubMed]
  • 15. Wayne PA. Implementation Guide of POCT for health care providers. 2007;
  • 16. Jamalludeen N, Johnson RP, Friendship R, Kropinski AM, Lingohr EJ, Gyles CL. Isolation and characterization of nine bacteriophages that lyse O149 enterotoxigenic Escherichia coli. Vet Microbiol. 2007; 124(1-2): 47-57[DOI][PubMed]
  • 17. Zimmer M, Scherer S, Loessner MJ. Genomic analysis of Clostridium perfringens bacteriophage phi3626, which integrates into guaA and possibly affects sporulation. J Bacteriol. 2002; 184(16): 4359-68[PubMed]
  • 18. Capra ML, Quiberoni A, Reinheimer J. Phages of Lactobacillus casei/paracasei: response to environmental factors and interaction with collection and commercial strains. J Appl Microbiol. 2006; 100(2): 334-42[DOI][PubMed]
  • 19. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning. 1989;
  • 20. van Regenmortel MH, Fauquet C, Bishop D, Carstens E, Estes M. Virus Taxonomy: Classification and Nomenclature of Viruses. Seventh Report of the International Committee on Taxonomy of Viruses. 2000;
  • 21. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970; 227(5259): 680-5[PubMed]
  • 22. Kutter E, Sulakvelidze A. Bacteriophages: biology and applications. 2004;
  • 23. Matsuzaki S, Rashel M, Uchiyama J, Sakurai S, Ujihara T, Kuroda M, et al. Bacteriophage therapy: a revitalized therapy against bacterial infectious diseases. J Infect Chemother. 2005; 11(5): 211-9[DOI][PubMed]
  • 24. Beheshti Maal K, Soleimani Delfan A, Salmanizadeh S. Isolation and Identification of Two Novel Escherichia coli Bacteriophages and Their Application in Wastewater Treatment and Coliform's Phage Therapy. Jundishapur J Microbiol. 2015; 8(3)[DOI][PubMed]
  • 25. Smith HW, Huggins MB. Successful treatment of experimental Escherichia coli infections in mice using phage: its general superiority over antibiotics. J Gen Microbiol. 1982; 128(2): 307-18[DOI][PubMed]
  • 26. Smith HW, Huggins MB, Shaw KM. Factors influencing the survival and multiplication of bacteriophages in calves and in their environment. J Gen Microbiol. 1987; 133(5): 1127-35[DOI][PubMed]
  • 27. Piracha Z, Saeed U, Khurshid A, Chaudhary WN. Isolation and partial characterization of virulent phage specific against Pseudomonas aeruginosa. Glob J Med Res. 2014; 14(1)
  • 28. Carey-Smith GV, Billington C, Cornelius AJ, Hudson JA, Heinemann JA. Isolation and characterization of bacteriophages infecting Salmonella spp. FEMS Microbiol Lett. 2006; 258(2): 182-6[DOI][PubMed]
  • 29. Hazem A. Effects of temperatures, pH-values, ultra-violet light, ethanol and chloroform on the growth of isolated thermophilic Bacillus phages. New Microbiol. 2002; 25(4): 469-76[PubMed]
  • 30. Jamal M, Hussain T, Das CR, Andleeb S. Characterization of Siphoviridae phage Z and studying its efficacy against multidrug-resistant Klebsiella pneumoniae planktonic cells and biofilm. J Med Microbiol. 2015; 64: 454-62[DOI][PubMed]
  • 31. Sillankorva S, Neubauer P, Azeredo J. Pseudomonas fluorescens biofilms subjected to phage phiIBB-PF7A. BMC Biotechnol. 2008; 8: 79[DOI][PubMed]
  • 32. Payne RJ, Jansen VA. Understanding bacteriophage therapy as a density-dependent kinetic process. J Theor Biol. 2001; 208(1): 37-48[DOI][PubMed]
  • 33. Weld RJ, Butts C, Heinemann JA. Models of phage growth and their applicability to phage therapy. J Theor Biol. 2004; 227(1): 1-11[DOI][PubMed]
  • 34. Ackermann HW. Phage Classification and Characterization. Bacteriophages.: Humana Press; 2009; : 127-40
  • 35. Park SC, Shimamura I, Fukunaga M, Mori KI, Nakai T. Isolation of bacteriophages specific to a fish pathogen, Pseudomonas plecoglossicida, as a candidate for disease control. Appl Environ Microbiol. 2000; 66(4): 1416-22[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments